PEG-Sulfate Colon-Cleansing Composition With Split-Dose Administration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bowel preparations for colon cleansing, such as those containing polyethylene glycol (PEG) and sulfate salts, suffer from patient discomfort, poor compliance, electrolyte imbalances, and safety concerns, including renal issues and hyponatremia, while requiring adjunct laxatives like bisacodyl.
Innovation Solution
A composition comprising PEG, sodium sulfate, magnesium sulfate, potassium chloride, and sodium chloride, balanced with flavoring agents and non-fermentable sugars, is administered in split doses to effectively cleanse the colon without the need for adjunct laxatives, improving taste and reducing gas production and electrolyte shifts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If large volume PEG-based preparations (GoLYTELY, NuLYTELY) are used for colon cleansing, then patient safety is improved, but patient compliance deteriorates due to large volume ingestion requirements
Solution Approach 1:
The total volume of PEG solution is divided into two separate doses administered at different times (evening before and morning of procedure). Each dose is packaged in separate containers with separate flavoring, allowing patients to consume smaller volumes at each administration rather than one large volume, thereby improving compliance while maintaining safety
Solution Approach 2:
Different flavoring agents are assigned to different doses (cherry flavor for evening dose, grape flavor for morning dose). This local differentiation makes each dose more palatable and acceptable to patients, addressing the compliance issue without compromising the cleansing efficacy
2Ease of operation
If phosphate-based preparations (Phosphosoda, Osmoprep) are used to reduce volume, then patient compliance is improved, but patient safety deteriorates due to renal failure risk
Solution Approach 1:
The osmotic agent is changed from phosphate to PEG, fundamentally altering the chemical composition to eliminate renal toxicity while maintaining the volume-reduced benefit. PEG provides osmotic cleansing without the calcium phosphate deposition risk associated with phosphate-based preparations
Solution Approach 2:
The preparation combines PEG with sulfate salts (magnesium sulfate, sodium sulfate) and balanced electrolytes (potassium chloride, sodium chloride) to create a composite formulation that achieves effective colon cleansing with reduced volume while maintaining electrolyte balance and patient safety
3Object-affected harmful factors
If MiraLax/Gatorade combination with bisacodyl is used, then taste is improved, but patient compliance deteriorates due to bloating and cramps
Solution Approach 1:
The formulation changes from PEG alone (MiraLax) to PEG combined with sulfate salts and balanced electrolytes. This compositional change maintains good taste through flavoring while eliminating the bloating and cramping side effects that occur with PEG-Gatorade combinations, thereby improving compliance
4Object-affected harmful factors
If PEG-based compositions are flavored with acidic components, then taste is improved, but PEG degradation occurs yielding unwanted byproducts
Solution Approach 1:
Sulfate salts are added to the PEG formulation beforehand to cushion or buffer against the degradation reaction. The sulfate prevents acidic flavoring agents from degrading the PEG, allowing the inclusion of flavorful components without generating unwanted byproducts
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition provides effective colon cleansing with improved patient tolerance, reduced volume requirements, and safety by avoiding clinically significant electrolyte shifts, while eliminating the need for stimulant laxatives and reducing fermentation-related issues.
Implementation Method 1
the isotonic large volume preparations GoLYTELY and NuLYTELY which are based on polyethylene glycol (PEG) as the osmotic agent
Implementation Method 2
SUPREP (based on sulfate as the osmotic agent)
Data Source
AI summary
Disclosed herein are methods of administering compositions comprising a mixture of salts that induce purgation of the colon and are useful to cleanse the colon. Furthermore, the disclosed methods prevent degradation of PEG and allow for cleansing of the colon without the use of adjunct laxatives, including stimulant laxatives such as bisacodyl. The disclosed methods are superior to the prior art in that they allow for higher tolerability, improved safety, lower volumes, and improved patient compliance.